ARSAC notes for guidance: good clinical practice in nuclear medicine
Guidance on licencing and best use of radiopharmaceuticals and sealed radioactive sources in diagnosis, treatment or research.
- From:
- Administration of Radioactive Substances Advisory Committee
- Published
- 17 April 2014
- Last updated
-
3125MayFebruary20242025 — See all updates
Documents
Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources
Ref: UKHSA publications gateway number GOV-15859
PDF, 681875 KB, 8586 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email arsac@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).
The MarchFebruary 20242025 version contains notable updates from the previous version, aswhich detailedis explained on page one.1.
Updates to this page
Published 17 April 2014
Last updated 3125 MayFebruary 2024
2025
+ show all updates
-
Updated ARSAC notes for guidance.
-
Updated links to the new applications portal.
-
-
Added March 2024 update.
-
-
Added February 2023 update.
-
-
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources' (see page 1 for the latest changes).
-
-
Edited ‘Section 3: Applying for a practitioner licence’.
-
-
Added February update.
-
-
Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
-
-
Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
-
-
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.
-
-
Updated notes to clarify the licencing process.
-
-
Replaced 'notes for guidance' document and updated detail text.
-
-
Uploaded the 2017 edition of guidance.
-
-
January 2016 update to guidance.
-
-
First published.
Sign up for emails or print this page
Details
This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).
The MarchFebruary 20242025 version contains notable updates from the previous version, aswhich detailedis explained on page one.1.
Updates to this page
Published 17 April 2014Last updated
-
Updated ARSAC notes for guidance.
-
Updated links to the new applications portal.
-
Added March 2024 update.
-
Added February 2023 update.
-
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources' (see page 1 for the latest changes).
-
Edited ‘Section 3: Applying for a practitioner licence’.
-
Added February update.
-
Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
-
Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
-
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.
-
Updated notes to clarify the licencing process.
-
Replaced 'notes for guidance' document and updated detail text.
-
Uploaded the 2017 edition of guidance.
-
January 2016 update to guidance.
-
First published.